In a preclinical baboon model of acquired thrombotic thrombocytopenic purpura, Callewaert et al. found that anti-VWF Nb ALX-0681 successfully treated the disease without evident risk of severe bleeding31. This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.